BioCentury
ARTICLE | Strategy

Formative years

Unlocking VCs' process of biotech company formation

January 25, 2016 8:00 AM UTC

VCs that spend a large chunk of their time and capital creating companies from scratch are planning to continue regardless of what happens with the financial markets. Althoughde novo company formation takes a lot of work and can take a lot of time, they say there is always a market for disruptive science, whether the buyers are public investors or pharma.

The VCs most active in company formation include Flagship Ventures, Arch Venture Partners, Third Rock Ventures, Avalon Ventures, Versant Ventures, Atlas Venture and Index Ventures, and each has its own approach to sourcing ideas and incubating and funding baby companies (see "Early to the Party," page 3)...